Page last updated: 2024-10-25

debrisoquin and Acute Confusional Senile Dementia

debrisoquin has been researched along with Acute Confusional Senile Dementia in 3 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benítez, J1
Barquero, MS1
Coria, F1
Molina, JA1
Jiménez-Jiménez, FJ1
Ladero, JM1
Liu, TY1
Chi, CW1
Yang, JC1
Cheung, SC1
Liu, HC1
Steventon, GB1
Heafield, MT1
Sturman, S1
Waring, RH1
Williams, AC1

Other Studies

3 other studies available for debrisoquin and Acute Confusional Senile Dementia

ArticleYear
Oxidative polymorphism of debrisoquine is not related to the risk of Alzheimer's disease.
    Journal of the neurological sciences, 1993, Volume: 117, Issue:1-2

    Topics: Aged; Alzheimer Disease; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Femal

1993
Debrisoquine metabolism in Chinese patients with Alzheimer's and Parkinson's diseases.
    Molecular and chemical neuropathology, 1992, Volume: 17, Issue:1

    Topics: Aged; Alzheimer Disease; China; Debrisoquin; Female; Humans; Male; Oxidation-Reduction; Parkinson Di

1992
Xenobiotic metabolism in Alzheimer's disease.
    Neurology, 1990, Volume: 40, Issue:7

    Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Carbocysteine; Debriso

1990